cancer of unknown primary
Showing 1 - 3 of 3
Cancer of Unknown Primary Trial in Shanghai (Recombinant humanized anti-PD-1 mAb injection)
Recruiting
- Cancer of Unknown Primary
- Recombinant humanized anti-PD-1 monoclonal antibody injection
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Apr 18, 2022
Solid Tumor, Stage III Pancreatic Cancer, Stage IIIA Breast Cancer Trial in Atlanta (Carboplatin, Cisplatin, Palbociclib)
Active, not recruiting
- Solid Neoplasm
- +16 more
- Carboplatin
- +2 more
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
Feb 28, 2022
Cancer of Unknown Primary, Bone Cancer Metastatic, Tislelizumab Trial in Shanghai (Tislelizumab plus chemo)
Recruiting
- Cancer of Unknown Primary
- +5 more
- Tislelizumab plus chemotherapy
-
Shanghai, Shanghai, ChinaChangZheng Hospital
Feb 6, 2022